RT Journal Article
SR Electronic
T1 Anxiolytic management in eating disorder patients receiving cognitive behavioral therapy: A quality improvement brief report
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.11.25.24317936
DO 10.1101/2024.11.25.24317936
A1 Smith, Brad E.R.
A1 Greenberg, Katelyn A.
A1 Vadapalli, Sreya
A1 Garrison, Sheldon R.
YR 2024
UL http://medrxiv.org/content/early/2024/11/27/2024.11.25.24317936.abstract
AB Eating disorders (EDs) are serious lifelong and debilitating health conditions characterized by complex adverse eating behaviors resulting in weight loss and decreased quality of life. One evidence-based treatment is a form of cognitive-behavioral therapy (CBT) called exposure therapy where patients progress through a hierachy of exposures. This treatment approach results in concern related to CBT efficacy for patients concurrently treated with anxiolytic medications. These medications, which are being incorporated into treatment protocols, may impact the anxiety-provoking components of the exposure response, potentially limiting its efficacy. Therefore, patients were assessed in multiple ways to ensure that providers could prescribe anxiolytics without risk to diminishing the well-established response to CBT. To ensure that patients treated with anxiolytics progressed at a similar rate to those who did not receive them, a quality improvement study was conducted to compare all patients in residential, partial hospitalization and intensive outpatient eating disorder treatment programs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the Rogers Behavioral Health Foundation and the Lynn S Nicholas Family Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This Rogers Behavioral Health Institutional Review Board of Rogers Behavioral Health determined that this quality improvement project was non-human subjects research and waived ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.